Vancomycin-Resistant Enterococci
3
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Theraworx Bath Wipes
Research Leaders
6 sponsors active, led by VA Office of Research and Development
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization
Investigation of the Optimal Cocktailed Probiotics for Decolonization of Vancomycin-resistant Enterococci in Human Gut
Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci
Research Network
Common Treatments
- Theraworx Bath Wipes1
- Probiotic Cocktail Capsules1
- Resistant Potato Starch1
- Maltodextrin1
- Standard Bath Wipes1
Active Sponsors
- VA Office of Research and Development1
- Delta Electronics1
- Taipei Medical University Shuang Ho Hospital1
- Avadim Technologies, Inc.1
- St. Jude Children's Research Hospital1
Top Investigators
St. Jude Children's Research Hospital
Taipei Medical University-ShuangHo Hospital
William S. Middleton Memorial Veterans Hospital, Madison, WI
Related Conditions
- Carbapenemresistant Enterobacteriaceae1
- Clostridium Infections1
- Hematopoietic Stem Cell Transplantation1
- Asymptomatic Infections1
- Probiotics1